High expression of apolipoprotein E mRNA in the brains with sporadic Alzheimer's disease

Dementia and Geriatric Cognitive Disorders

Volumn 12, Issue 2, 2001, Pages 57-62

  Yamagata, Kaoru ^a   Urakami, Katsuya ^a   Ikeda, Kazuyuki ^a   Ji, Yong ^a   Adachi, Yoshiki ^a   Arai, Hiroyuki ^b   Sasaki, Hidetada ^b   Sato, Kenzo ^a   Nakashima, Kenji ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apolipoprotein E; Apolipoprotein E mRNA; Apolipoprotein E 4; Sporadic Alzheimer's disease

Indexed keywords

APOLIPOPROTEIN E; MESSENGER RNA;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; GENOTYPE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEINS E; BRAIN; FEMALE; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0035127966     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000051236     Document Type: Article

References (27)

1. Apolipoprotein E in patients with dementia of the Alzheimer type and vascular dementia
2. Apolipoprotein E polymorphism in patients with Alzheimer's disease, vascular dementia and ischemic cerebrovascular disease
3. Binding of human apolipoprotein E to synthetic amyloid β peptide: Isoform-specific effects and implications for late-onset Alzheimer disease
4. The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtuble depolymeration
5. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and β-amyloid peptide
6. Apolipoprotein E mRNA in the brains of patients with Alzheimer's disease
7. Increased apolipoprotein E mRNA in the hippocampus in Alzheimer disease and in rats after entorhinal cortex lesioning
8. Apolipoprotein abnormalities in dementia
9. Intra vitam lumbar cerebrospinal fluid and serum and postmortem ventricular immunoreactive apolipoprotein E in patients with Alzheimer's disease
10. Increased plasma apolipoprotein E (apoE) levels in Alzheimer's disease
11. Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's disease
12. Cerebrospinal fluid apo E and apo A-I concentrations in early- and late-onset Alzheimer's disease
13. Cerebrospinal fluid apolipoprotein E level increased in late-onset Alzheimer's disease
14. A minimally lipidated form of cell-derived apolipoprotein E exhibits isoform-specific stimulation of neurite outgrowth in the absence of exogenous lipids or lipoproteins
15. ApoE4-associated Alzheimer's disease risk is modified byα1-antichymotrypsin polymorphism
16. Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease
17. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia
18. A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease
19. Diagnosis of Alzheimer's disease
20. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction
21. Isolation, characterization, and mapping to chromosome 19 of the human apolipoprotein E gene
22. Molecular structure of the human cytoplasmic beta-actin gene: Interspecies homology of sequence in the intrins
23. Apolipoprotein E genotyping by one-stage PCR
24. Expression of human apolipoprotein E reduces amyloid-β deposition in a mouse model of Alzheimer's disease
25. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and β-amyloid peptides